Enveric Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ADVISORSHARES INVESTMENTS LLC | 02/14/2025 | 599,854 | $214,988 | 63.43% | 6.89% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 216,594 | $77,626 | -0.60% | 2.49% |
| UBS GROUP AG | 02/14/2025 | 78,408 | $28,070 | 10,626.13% | 0.90% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 55,763 | $20,000 | 141.22% | 0.64% |
| TWO SIGMA SECURITIES, LLC | 02/14/2025 | 31,872 | $11,423 | 4.05% | 0.37% |
| XTX TOPCO LTD | 02/13/2025 | 22,007 | $7,887 | 100.00% | 0.25% |
| VANGUARD GROUP INC | 02/11/2025 | 18,198 | $6,515 | 0.00% | 0.21% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 12,145 | $4,353 | -9.26% | 0.14% |
| JANE STREET GROUP, LLC | 02/14/2025 | 10,815 | $3,876 | 100.00% | 0.12% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 9,010 | $3,229 | 0.00% | 0.10% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 8,810 | $3,154 | -49.29% | 0.10% |
| GROUP ONE TRADING, L.P. | 02/14/2025 | 273 | $98 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 150 | $70 | -73.91% | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 02/12/2025 | 70 | $25 | -1.41% | 0.00% |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | 01/17/2025 | 50 | $17 | 0.00% | 0.00% |
| 02/06/2025 | 19 | $7 | 100.00% | 0.00% | |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 16 | $6 | 0.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Enveric Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 19 institutional investors and hedge funds held shares of Enveric Biosciences, Inc.. The most heavily invested institutionals were:
AdvisorShares Investments LLC: 599,854
GEODE CAPITAL MANAGEMENT, LLC: 216,594
UBS Group AG: 78,408
Virtu Financial LLC: 55,763
TWO SIGMA SECURITIES, LLC: 31,872
XTX Topco Ltd: 22,007
12.40% of Enveric Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.11 M shares in the last 24 months. This purchase volume represents approximately $464,746 in transactions.